Single Cell RNA Sequencing Enables Identification of Mantle Cell Lymphoma Subclones with Drug-Resistant Profiles Already at Diagnosis and May be Used for Therapy Prognostication and Personalization

MLA

Kazantsev, Dmitry, et al. “Single Cell RNA Sequencing Enables Identification of Mantle Cell Lymphoma Subclones with Drug-Resistant Profiles Already at Diagnosis and May Be Used for Therapy Prognostication and Personalization.” Blood, vol. 142, no. 1, Number 1 Supplement 1, Nov. 2023, p. 3004. EBSCOhost, https://doi.org/10.1182/blood-2023-185925.

APA

Kazantsev, D., Klanova, M., Kolář, M., Ivánek, R., Trněný, M., & Klener, P. (2023). Single Cell RNA Sequencing Enables Identification of Mantle Cell Lymphoma Subclones with Drug-Resistant Profiles Already at Diagnosis and May be Used for Therapy Prognostication and Personalization. Blood, 142(1, Number 1 Supplement 1), 3004. https://doi.org/10.1182/blood-2023-185925

Chicago

Kazantsev, Dmitry, Magdalena Klanova, Michal Kolář, Robert Ivánek, Marek Trněný, and Pavel Klener. 2023. “Single Cell RNA Sequencing Enables Identification of Mantle Cell Lymphoma Subclones with Drug-Resistant Profiles Already at Diagnosis and May Be Used for Therapy Prognostication and Personalization.” Blood 142 (1, Number 1 Supplement 1): 3004. doi:10.1182/blood-2023-185925.